Presentation TCT 2017

Switching Between Oral P2Y12 Receptor Inhibitors: When and How?

Presenter: Matthew J. Price

October 30, 2017

REGISTER for free or LOG IN to view this content

Switching Between Oral P2Y12 Receptor Inhibitors: When and How?

Coronary

Presentation

TCT 2017

CAD Pharma

Up Next

Presentation TCT 2017

Switching to and From Cangrelor: When and How?

Presenter: Dominick J. Angiolillo

October 30, 2017

More slides +

Presentation TCT 2017

Utility of Genotyping and Platelet Function Testing to Guide Antiplatelet Therapy: 2017 Assessment

Presenter: Thomas Engstroem

October 30, 2017

Presentation TCT 2017

Rationale and Studies of P2Y12 Inhibitor Monotherapy

Presenter: Roxana Mehran

October 30, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.